SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.90-1.7%Nov 28 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (20746)5/14/1998 10:32:00 AM
From: D.Lu  Read Replies (1) of 32384
 
A 14-month Phase 2 trial studying the interaction of the drugs adramycin and taxotere in treating breast cancer is seeking enrollees here. Earlier this was the site of research study conducted on tamoxifin. Is this latest trial somehow related to what Ligand is doing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext